← FDA Drug Approvals (Drugs@FDA)
TASIMELTEON
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2023-01-12
Drug application
- FDA Application #
ANDA211654- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TASIMELTEON
- Generic name
- TASIMELTEON
- Active ingredients
- TASIMELTEON
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- MSN
- Manufacturer
- Amneal Pharmaceuticals NY LLC
- First approval
- 2023-01-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown